GB201418043D0 - MicroRNA signatures for cardiac disorders - Google Patents

MicroRNA signatures for cardiac disorders

Info

Publication number
GB201418043D0
GB201418043D0 GBGB1418043.4A GB201418043A GB201418043D0 GB 201418043 D0 GB201418043 D0 GB 201418043D0 GB 201418043 A GB201418043 A GB 201418043A GB 201418043 D0 GB201418043 D0 GB 201418043D0
Authority
GB
United Kingdom
Prior art keywords
cardiac disorders
microrna signatures
microrna
signatures
cardiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1418043.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GBGB1418043.4A priority Critical patent/GB201418043D0/en
Publication of GB201418043D0 publication Critical patent/GB201418043D0/en
Priority to PCT/BE2015/000050 priority patent/WO2016058061A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C12N2320/11—Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
GBGB1418043.4A 2014-10-13 2014-10-13 MicroRNA signatures for cardiac disorders Ceased GB201418043D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1418043.4A GB201418043D0 (en) 2014-10-13 2014-10-13 MicroRNA signatures for cardiac disorders
PCT/BE2015/000050 WO2016058061A1 (en) 2014-10-13 2015-10-13 microRNA SIGNATURES FOR CARDIAC DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1418043.4A GB201418043D0 (en) 2014-10-13 2014-10-13 MicroRNA signatures for cardiac disorders

Publications (1)

Publication Number Publication Date
GB201418043D0 true GB201418043D0 (en) 2014-11-26

Family

ID=52001297

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1418043.4A Ceased GB201418043D0 (en) 2014-10-13 2014-10-13 MicroRNA signatures for cardiac disorders

Country Status (2)

Country Link
GB (1) GB201418043D0 (en)
WO (1) WO2016058061A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020171889A1 (en) * 2019-02-19 2020-08-27 University Of Rochester Blocking lipid accumulation or inflammation in thyroid eye disease
CN111154866A (en) * 2020-03-05 2020-05-15 北京市心肺血管疾病研究所 miRNA marker for predicting complicated myocardial hypertrophy of hypertension patient and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010019574A1 (en) * 2008-08-11 2010-02-18 The Board Of Regents Of The University Of Texas System A micro-rna that promotes vascular integrity and uses thereof
AU2010242163B2 (en) * 2009-04-29 2014-10-16 Academisch Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
WO2010130351A1 (en) * 2009-05-15 2010-11-18 Bayer Schering Pharma Ag Micrornas as biomarkers and therapeutic targets for heart failure
CN102416184A (en) * 2011-12-08 2012-04-18 哈尔滨医科大学 Application of antisense locked nucleotide sequence of microRNA-1 in preparation of medicines used for preventing or treating heart failure after myocardial infarction

Also Published As

Publication number Publication date
WO2016058061A1 (en) 2016-04-21

Similar Documents

Publication Publication Date Title
GB201517022D0 (en) No details
GB201410907D0 (en) No details
GB201519531D0 (en) No details
GB201517404D0 (en) No details
IL248856A0 (en) New treatment
PT3094237T (en) Electrocardiograph
GB201418217D0 (en) No details
GB201418216D0 (en) No details
GB201407322D0 (en) Gene therapy
IL250017A0 (en) Ophthalmoscopes
HK1245092A1 (en) Poultice
GB201517412D0 (en) No details
SG11201606199SA (en) Ketoprofen-containing poultice
GB201516796D0 (en) No details
IL251255A0 (en) Electrocoagulation reactor
GB201517574D0 (en) No details
GB201408823D0 (en) Demulsifiers
SG11201700652PA (en) Modified antimir-138 oligonucleotides
GB201517605D0 (en) No details
GB201418043D0 (en) MicroRNA signatures for cardiac disorders
GB201410910D0 (en) No details
GB201414431D0 (en) Improved electrodeposition
GB201604703D0 (en) NO details
GB201604701D0 (en) No Details
GB201604704D0 (en) No details

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)